Mode
Text Size
Log in / Sign up

Clinical Trial Search

Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.

Phase
Intervention
Population
Results posted

65,437 trials

Phase 2 N=444 Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Microsatellite-instability (MSI) High Colorectal Cancer (CRC) · Endometrial Cancer · Head and Neck Cancer
Primary: Phase 1: Percentage of Participants With Treatment-Emergent Adverse Events (TEAE) and Serious Treatment-Emergent Adverse Events — 0; 40.0; 50.0; 45.0 Percentage of…
Incyte Corporation Results Dec 2019 49.8% serious AE View details

Phase 3 N=702 Pediatric Open-Label Extension Study

Schizophrenia · Autism · Bipolar Depression
Primary: Number of Subjects With Adverse Events (AEs), Discontinuations Due to AEs and Serious AEs (SAEs) — 214; 106; 252; 572 Participants
Sumitomo Pharma America, Inc. Results Dec 2019 11.1% serious AE View details